# Omanta landing page growth report

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-s26/omanta
Source observed: 2026-09-30T02:41:50.241Z
Last checked: 2026-10-17T09:07:29.56+00:00
Indexed: 2026-09-30T06:51:09.664+00:00

---

# Omanta landing page growth report

We are reviewing Omanta’s landing page at [omanta.com](https://omanta.com/) through Lazyweb’s Growth Score report for YC S26. Omanta’s landing page describes itself with the headline **“A research lab For One.”** and the supporting line **“Built around your options. And what comes next.”**

## Overall score

- **Growth score:** 53 of 100
- **Updated:** Sep 20, 2026
- **Weakest area:** Trust
- **Ranking:** 3rd among the four entries shown

| Rank | Entry | Score |
|---:|---|---:|
| 1 | [The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r](https://www.lazyweb.com/growth-score/site/ciitizen.com) | 68 |
| 2 | [Perlara](https://www.lazyweb.com/growth-score/site/perlara.com) | 60 |
| 3 | Omanta | 53 |
| 4 | [Every Cure](https://www.lazyweb.com/growth-score/site/everycure.org) | 46 |

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Category scores

| Category | Score | Rating shown |
|---|---:|---|
| Trust | 34 | Poor |
| CTA | 48 | Poor |
| Value props | 48 | Poor |
| Mobile web | 62 | Fair |
| Information hierarchy | 72 | Fair |

- [Trust — 34](https://www.lazyweb.com/yc-s26/omanta#gs-trust)
- [CTA — 48](https://www.lazyweb.com/yc-s26/omanta#gs-cta)
- [Value props — 48](https://www.lazyweb.com/yc-s26/omanta#gs-value_props)
- [Mobile web — 62](https://www.lazyweb.com/yc-s26/omanta#gs-mobile_web)
- [Information hierarchy — 72](https://www.lazyweb.com/yc-s26/omanta#gs-information_hierarchy)

## Score over time

The report includes a score-over-time chart for Omanta and the comparison entries. The supplied text does not provide the chart’s individual historical data points.

## Trust — 34, Poor

Trust measures proof that the product is real, competent, and safe to try.

The report identifies **no visible trust signal** for Omanta. The comparison reads are:

| Entry | Trust read |
|---|---|
| Omanta | No visible trust signal identified. |
| Perlara | Specific disease-area copy: “congenital disorders of glycosylation, mitochondrial disorders, GPI-anchor defects, tRNA-sy…” |
| Every Cure | Photograph of a clinician consulting with a hospital patient behind the hero headline |
| The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r | “Helping thousands of families and trusted by 100+ patient communities” |

Trust ranking within this category:

1. The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r — 58
2. Perlara — 48
3. Every Cure — 44
4. Omanta — 34

[Build proof section](https://www.lazyweb.com/backlog?site=omanta.com#opt-trust-signals) to choose proof signals and receive copy and placement for a stronger trust section.

## CTA — 48, Poor

This category evaluates CTA copy, size, verb, and cost-feel. The report identifies these problems:

- The CTA is a nav link with no hero button.
- It is tiny compared with the very large headline.
- **“Conversation”** feels committal.
- It is invisible in the mobile hero.

CTA ranking:

1. Perlara — 72
2. The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r — 72
3. Omanta — 48
4. Every Cure — 48

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=omanta.com#opt-cta-writing) to generate primary and secondary options grounded in Omanta’s offer and visitor objections.

## Value props — 48, Poor

The report reviews whether the title, subtitle, and hero sell Omanta’s value.

### Landing-page copy reviewed

> **“A research lab For One.”**
>
> “Built around your options. And what comes next.”

### What is working

- **“For One”** signals deep personalization.
- The tone is emotionally resonant and human.
- The phrasing is distinctive and memorable.

### What could improve

- The copy never says what Omanta actually does.
- It gives no concrete outcome or deliverable.
- The hero art decorates rather than demonstrates anything.

Value-proposition ranking:

1. Perlara — 72
2. The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r — 62
3. Every Cure — 58
4. Omanta — 48

## Mobile web — 62, Fair

The mobile review identifies two issues. The supplied mobile capture is shown below.

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/omanta.com-mobile.jpg?v=2026-09-20T05%3A15%3A09.372%2B00%3A00)

1. **Begin a conversation link:** The only CTA is a small, unstyled text link in the header, making it too small to tap and easy to miss.
2. **Collapsed nav row:** “Approach,” “For Clinicians,” and “Leadership” disappear on mobile, with no hamburger menu to reach them.

[View mobile fixes](https://www.lazyweb.com/backlog?site=omanta.com#opt-mobile-web) to convert these findings into a prioritized implementation checklist.

## Information hierarchy — 72, Fair

The supplied desktop capture shows the annotated landing-page layout.

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/omanta.com.jpg?v=2026-09-20T05%3A15%3A09.372%2B00%3A00)

1. **Begin a conversation link:** The primary CTA is rendered as plain navigation text with the same weight as the three exit links beside it.
2. **Nav link row:** “Approach,” “For Clinicians,” and “Leadership” have equal visual weight with the CTA, drawing attention away before action.
3. **Subhead “Built around Omanta’s options.”:** The three-line, mixed-size stack reads as fragments and differs from mobile’s “Built around Omanta.”

[View layout plan](https://www.lazyweb.com/backlog?site=omanta.com#opt-information-hierarchy) to turn these callouts into a sequenced page plan.

## Competitors and comparison entries

The report infers these entries from product, audience, and value proposition:

1. [The Institute for Follicular Lymphoma Innovation (Private Medical-style N-of-1 r — ciitizen.com — 68](https://www.lazyweb.com/growth-score/site/ciitizen.com)
2. [Perlara — perlara.com — 60](https://www.lazyweb.com/growth-score/site/perlara.com)
3. **Omanta — 53**
4. [Every Cure — everycure.org — 46](https://www.lazyweb.com/growth-score/site/everycure.org)

### Related report actions

- [Back to YC S26](https://www.lazyweb.com/yc-s26)
- [Build proof section](https://www.lazyweb.com/backlog?site=omanta.com#opt-trust-signals)
- [Rewrite this CTA](https://www.lazyweb.com/backlog?site=omanta.com#opt-cta-writing)
- [View mobile fixes](https://www.lazyweb.com/backlog?site=omanta.com#opt-mobile-web)
- [View layout plan](https://www.lazyweb.com/backlog?site=omanta.com#opt-information-hierarchy)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Fomanta&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Fomanta). Opening a form does not execute a tool.